About Welltech Pharmaceuticals Private Limited
Data last updated:
Welltech Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC338259. Its GSTIN is 07AACCW2697Q1ZG (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sangeeta Singh and Dimple Singh.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 15/1 First Floor, Wazirpur Industrial Area, Delhi, India – 110052.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.81 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹3.17 Lakh (net margin 10%) and EBITDA of ₹3.18 Lakh (EBITDA margin 10%). Revenue has declined at a compounded annual rate (CAGR) of 74% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website welltechpharma.com.
Company details
Contact details
Welltech Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is welltechpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC – 15/1 First Floor, Wazirpur Industrial Area, Delhi, India – 110052
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Welltech Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Welltech Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Welltech Pharmaceuticals Private Limited, buy the company report.
Financials of Welltech Pharmaceuticals Private Limited
FY 2025 filings availableWelltech Pharmaceuticals Private Limited reported revenue of ₹31.81 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 10% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Welltech Pharmaceuticals Private Limited, buy the company report.
Board of directors of Welltech Pharmaceuticals Private Limited
Welltech Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeeta Singh Also directs: Khokar Associates Limited, Hercules Nutra Private Limited | Director | 04 Sep 2018 | 8 Years 1 Months | Current |
| Dimple Singh | Director | 04 Sep 2018 | 8 Years 1 Months | Current |
| Amit Singh Also directs: Medglobe Therapeutics Limited, Khokar Associates Limited | Director | 04 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Welltech Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Events and Entertainment industry (Entertainment Venues, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hexine Pharmaceuticals Private Limited | ₹31.91 Lakh (FY 2025) | 163.0% | New Delhi, Delhi, India | |||
| Venetic Pharmaceuticals Private Limited | ₹31.85 Lakh (FY 2025) | 23.0% | Patna, Bihar, India | |||
| Remission Pharmaceuticals Private Limited | ₹31.83 Lakh (FY 2025) | 145.0% | Hyderabad, Telangana, India | |||
| Welltech Pharmaceuticals Private Limitedthis company | ₹31.81 Lakh (FY 2025) | ₹3.17 Lakh | 10% | 11.0% | Delhi, India | |
| VCC Formulation Private Limited | ₹31.74 Lakh (FY 2022) | 8.0% | Allahabad, Uttar Pradesh, India | |||
| Armiya Pharmaceuticals Private Limited | ₹31.69 Lakh (FY 2025) | 0.0% | Bareilly, Uttar Pradesh, India |
To see the full peer comparison of Welltech Pharmaceuticals Private Limited, buy the company report.
Auditor
Welltech Pharmaceuticals Private Limited is audited by AGARWAL MANOJ NIDHI & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL MANOJ NIDHI & ASSOCIATES | FY 2021 | 019011C |
Shareholding
The shareholding of Welltech Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Welltech Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Welltech Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Welltech Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Welltech Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCW2697Q1ZG | Delhi | Active | 17 Dec 2018 |
To see the full GST registrations and return filing status of Welltech Pharmaceuticals Private Limited, buy the company report.
Recent activity
Welltech Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Amit Singh was appointed as Director on 04 Sep 2018.
Frequently asked questions
Welltech Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 2018 (8+ years old) and is registered under CIN U51909DL2018PTC338259.
Welltech Pharmaceuticals has 3 current directors:
- Sangeeta Singh - Director
- Dimple Singh - Director
- Amit Singh - Director
The latest financial statements of Welltech Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Welltech Pharmaceuticals is 07AACCW2697Q1ZG, registered in Delhi.
The CIN (Corporate Identification Number) of Welltech Pharmaceuticals is U51909DL2018PTC338259. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Welltech Pharmaceuticals was incorporated on 04 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Welltech Pharmaceuticals by revenue are Hexine Pharmaceuticals Private Limited, Venetic Pharmaceuticals Private Limited, Remission Pharmaceuticals Private Limited, VCC Formulation Private Limited, Armiya Pharmaceuticals Private Limited, all in the Events and Entertainment industry (Entertainment Venues, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Singh was appointed as Director on 04 Sep 2018. Dimple Singh was appointed as Director on 04 Sep 2018. Sangeeta Singh was appointed as Director on 04 Sep 2018.
Welltech Pharmaceuticals can be reached through the website welltechpharma.com. Its registered office is in Delhi, India.
The registered office of Welltech Pharmaceuticals is at C – 151 First Floor, Wazirpur Industrial Area, Delhi, India – 110052.
Welltech Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.